Medtech company Wenzel Spine received FDA clearance for panaSIa, an expandable sacroiliac fusion implant.
The implant offers a minimally invasive procedure option for patients with sacroiliac joint dysfunction, according to a July 15 news release from Wenzel Spine.
The approval marks the first FDA clearance of an expandable SI fusion implant.
The system separates the joint surfaces and minimizes micro-motion in the joint to provide immediate fixation and stabilize the joint for fusion, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
